Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1989 Mar;150(3):319–328.

The past, present, and future of pertussis. The role of adults in epidemiology and future control.

J D Cherry, L J Baraff, E Hewlett
PMCID: PMC1026455  PMID: 2660414

Abstract

Pertussis is a severe epidemic disease that causes significant morbidity and mortality in unimmunized children. It is now clear, however, that adults with atypical disease account for many of the cases and are often responsible for transmission to susceptible infants. Because of the extent of unrecognized pertussis in the adult population, mass pediatric immunization has been successful in controlling the disease in children but not in reducing the presence of the organism in the United States. Pertussis immunization of children is associated with a high rate of side reactions and is temporally related to severe neurologic disease and death in infants. These events are often considered to be reactions, but available scientific evidence indicates that few, if any, are actually caused by pertussis immunization. Pertussis vaccine reactogenicity in adults is anecdotally considered to be worse than in children, but direct studies do not support that. In the context of current programs emphasizing adult immunization, consideration should be given to booster doses of diphtheria-tetanus-pertussis in adults, using component pertussis vaccines when they become available.

Full text

PDF
319

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARTA G. Soluble protective antigen from Bordetella pertussis prepared with sodium desoxycholate. J Immunol. 1963 Jan;90:72–80. [PubMed] [Google Scholar]
  2. BERG J. M. Neurological complications of pertussis immunization. Br Med J. 1958 Jul 5;2(5087):24–27. doi: 10.1136/bmj.2.5087.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BYERS R. K., MOLL F. C. Encephalopathies following prophylactic pertussis vaccine. Pediatrics. 1948 Apr;1(4):437–457. [PubMed] [Google Scholar]
  4. Baraff L. J., Ablon W. J., Weiss R. C. Possible temporal association between diphtheria-tetanus toxoid-pertussis vaccination and sudden infant death syndrome. Pediatr Infect Dis. 1983 Jan-Feb;2(1):7–11. doi: 10.1097/00006454-198301000-00003. [DOI] [PubMed] [Google Scholar]
  5. Baraff L. J., Cherry J. D., Cody C. L., Marcy S. M., Manclark C. R. DTP vaccine reactions: effect of prior reactions on rate of subsequent reactions. Dev Biol Stand. 1985;61:423–428. [PubMed] [Google Scholar]
  6. Baraff L. J., Cody C. L., Cherry J. D. DTP-associated reactions: an analysis by injection site, manufacturer, prior reactions, and dose. Pediatrics. 1984 Jan;73(1):31–36. [PubMed] [Google Scholar]
  7. Baraff L. J., Shields W. D., Beckwith L., Strome G., Marcy S. M., Cherry J. D., Manclark C. R. Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation. Pediatrics. 1988 Jun;81(6):789–794. [PubMed] [Google Scholar]
  8. Bassili W. R., Stewart G. T. Epidemiological evaluation of immunisation and other factors in the control of whooping-cough. Lancet. 1976 Feb 28;1(7957):471–474. doi: 10.1016/s0140-6736(76)91488-4. [DOI] [PubMed] [Google Scholar]
  9. Bellman M. H., Ross E. M., Miller D. L. Infantile spasms and pertussis immunisation. Lancet. 1983 May 7;1(8332):1031–1034. doi: 10.1016/s0140-6736(83)92655-7. [DOI] [PubMed] [Google Scholar]
  10. Björkholm B., Böttiger M., Christenson B., Hagberg L. Antitoxin antibody levels and the outcome of illness during an outbreak of diphtheria among alcoholics. Scand J Infect Dis. 1986;18(3):235–239. doi: 10.3109/00365548609032332. [DOI] [PubMed] [Google Scholar]
  11. Brown D. R., Parker C. D. Cloning of the filamentous hemagglutinin of Bordetella pertussis and its expression in Escherichia coli. Infect Immun. 1987 Jan;55(1):154–161. doi: 10.1128/iai.55.1.154-161.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Burstyn D. G., Baraff L. J., Peppler M. S., Leake R. D., St Geme J., Jr, Manclark C. R. Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun. 1983 Sep;41(3):1150–1156. doi: 10.1128/iai.41.3.1150-1156.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Centers for Disease Control (CDC) Annual summary 1981. Reported morbidity & mortality in the United States. MMWR Morb Mortal Wkly Rep. 1982 Oct;30(54):1–132. [PubMed] [Google Scholar]
  14. Centers for Disease Control (CDC) Pertussis surveillance, 1979-1981. MMWR Morb Mortal Wkly Rep. 1982 Jul 2;31(25):333–336. [PubMed] [Google Scholar]
  15. Centers for Disease Control (CDC) Pertussis--United States, 1982 and 1983. MMWR Morb Mortal Wkly Rep. 1984 Oct 12;33(40):573–575. [PubMed] [Google Scholar]
  16. Cherry J. D., Shields W. D. Recurrent seizures after diphtheria, tetanus, and pertussis immunization. Cause and effect v temporal association. Am J Dis Child. 1984 Oct;138(10):904–907. doi: 10.1001/archpedi.1984.02140480006002. [DOI] [PubMed] [Google Scholar]
  17. Cherry J. D. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr. 1984 Feb;14(2):1–78. doi: 10.1016/0045-9380(84)90016-1. [DOI] [PubMed] [Google Scholar]
  18. Dyer C. Judge "not satisfied" that whooping cough vaccine causes permanent brain damage. Br Med J (Clin Res Ed) 1988 Apr 23;296(6630):1189–1190. doi: 10.1136/bmj.296.6630.1189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. FELTON H. M., VERWEY W. F. The epidemiological evaluation of a non-cellular pertussis antigen. Pediatrics. 1955 Nov;16(5):637–651. [PubMed] [Google Scholar]
  20. Fine P. E., Clarkson J. A. The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. Lancet. 1982 Mar 20;1(8273):666–669. doi: 10.1016/s0140-6736(82)92214-0. [DOI] [PubMed] [Google Scholar]
  21. GORDON J. E., HOOD R. I. Whooping cough and its epidemiological anomalies. Am J Med Sci. 1951 Sep;222(3):333–361. doi: 10.1097/00000441-195109000-00011. [DOI] [PubMed] [Google Scholar]
  22. Granström M., Thorén M., Blennow M., Tiru M., Sato Y. Acellular pertussis vaccine in adults: adverse reactions and immune response. Eur J Clin Microbiol. 1987 Feb;6(1):18–21. doi: 10.1007/BF02097184. [DOI] [PubMed] [Google Scholar]
  23. Hewlett E. L. Selective primary health care: strategies for control of disease in the developing world. XVII. Pertussis and diphtheria. Rev Infect Dis. 1985 May-Jun;7(3):426–433. doi: 10.1093/clinids/7.3.426. [DOI] [PubMed] [Google Scholar]
  24. Hoffman H. J., Hunter J. C., Damus K., Pakter J., Peterson D. R., van Belle G., Hasselmeyer E. G. Diphtheria-tetanus-pertussis immunization and sudden infant death: results of the National Institute of Child Health and Human Development Cooperative Epidemiological Study of Sudden Infant Death Syndrome risk factors. Pediatrics. 1987 Apr;79(4):598–611. [PubMed] [Google Scholar]
  25. Kendrick P. L., Eldering G., Dixon M. K., Misner J. Mouse Protection Tests in the Study of Pertussis Vaccine: A Comparative Series Using the Intracerebral Route for Challenge. Am J Public Health Nations Health. 1947 Jul;37(7):803–810. [PMC free article] [PubMed] [Google Scholar]
  26. Kendrick P., Eldering G. Progress Report on Pertussis Immunization. Am J Public Health Nations Health. 1936 Jan;26(1):8–12. doi: 10.2105/ajph.26.1.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kurt T. L., Yeager A. S., Guenette S., Dunlop S. Spread of pertussis by hospital staff. JAMA. 1972 Jul 17;221(3):264–267. [PubMed] [Google Scholar]
  28. LAMBERT H. J. EPIDEMIOLOGY OF A SMALL PERTUSSIS OUTBREAK IN KENT COUNTY, MICHIGAN. Public Health Rep. 1965 Apr;80:365–369. [PMC free article] [PubMed] [Google Scholar]
  29. Linnemann C. C., Jr, Bass J. W., Smith M. H. The carrier state in pertussis. Am J Epidemiol. 1968 Nov;88(3):422–427. doi: 10.1093/oxfordjournals.aje.a120903. [DOI] [PubMed] [Google Scholar]
  30. Linnemann C. C., Jr, Nasenbeny J. Pertussis in the adult. Annu Rev Med. 1977;28:179–185. doi: 10.1146/annurev.me.28.020177.001143. [DOI] [PubMed] [Google Scholar]
  31. Locht C., Keith J. M. Pertussis toxin gene: nucleotide sequence and genetic organization. Science. 1986 Jun 6;232(4755):1258–1264. doi: 10.1126/science.3704651. [DOI] [PubMed] [Google Scholar]
  32. MALMGREN B., VAHLQUIST B., ZETTERSTROM R. Complications of immunization. Br Med J. 1960 Dec 17;2(5215):1800–1801. doi: 10.1136/bmj.2.5215.1800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. MILLER H. G., STANTON J. B. Neurological sequelae of prophylactic inoculation. Q J Med. 1954 Jan;23(89):1–27. [PubMed] [Google Scholar]
  34. Melchior J. C. Infantile spasms and early immunization against whooping cough. Danish survey from 1970 to 1975. Arch Dis Child. 1977 Feb;52(2):134–137. doi: 10.1136/adc.52.2.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Miller D. L., Ross E. M., Alderslade R., Bellman M. H., Rawson N. S. Pertussis immunisation and serious acute neurological illness in children. Br Med J (Clin Res Ed) 1981 May 16;282(6276):1595–1599. doi: 10.1136/bmj.282.6276.1595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Miller D., Wadsworth J., Diamond J., Ross E. Pertussis vaccine and whooping cough as risk factors in acute neurological illness and death in young children. Dev Biol Stand. 1985;61:389–394. [PubMed] [Google Scholar]
  37. Morse S. I. Pertussis in adults. Ann Intern Med. 1968 Apr;68(4):953–954. doi: 10.7326/0003-4819-68-4-953. [DOI] [PubMed] [Google Scholar]
  38. Mortimer E. A., Jr, Jones P. K., Adelson L. DTP and SIDS. Pediatr Infect Dis. 1983 Nov-Dec;2(6):492–493. doi: 10.1097/00006454-198311000-00020. [DOI] [PubMed] [Google Scholar]
  39. Mortimer E. A., Jr, Jones P. K. An evaluation of pertussis vaccine. Rev Infect Dis. 1979 Nov-Dec;1(6):927–934. doi: 10.1093/clinids/1.6.927. [DOI] [PubMed] [Google Scholar]
  40. Nelson J. D. The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection. Am J Dis Child. 1978 Apr;132(4):371–373. doi: 10.1001/archpedi.1978.02120290043006. [DOI] [PubMed] [Google Scholar]
  41. Nicosia A., Perugini M., Franzini C., Casagli M. C., Borri M. G., Antoni G., Almoni M., Neri P., Ratti G., Rappuoli R. Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4631–4635. doi: 10.1073/pnas.83.13.4631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Noble G. R., Bernier R. H., Esber E. C., Hardegree M. C., Hinman A. R., Klein D., Saah A. J. Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists. JAMA. 1987 Mar 13;257(10):1351–1356. [PubMed] [Google Scholar]
  43. Pittman M. The concept of pertussis as a toxin-mediated disease. Pediatr Infect Dis. 1984 Sep-Oct;3(5):467–486. doi: 10.1097/00006454-198409000-00019. [DOI] [PubMed] [Google Scholar]
  44. Pollock T. M., Morris J. A 7-year survey of disorders attributed to vaccination in North West Thames region. Lancet. 1983 Apr 2;1(8327):753–757. doi: 10.1016/s0140-6736(83)92037-8. [DOI] [PubMed] [Google Scholar]
  45. Prensky A. L. Pertussis vaccination. Dev Med Child Neurol. 1974 Aug;16(4):539–543. doi: 10.1111/j.1469-8749.1974.tb03382.x. [DOI] [PubMed] [Google Scholar]
  46. Romanus V., Jonsell R., Bergquist S. O. Pertussis in Sweden after the cessation of general immunization in 1979. Pediatr Infect Dis J. 1987 Apr;6(4):364–371. doi: 10.1097/00006454-198704000-00005. [DOI] [PubMed] [Google Scholar]
  47. Sato Y., Izumiya K., Sato H., Cowell J. L., Manclark C. R. Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect Immun. 1981 Mar;31(3):1223–1231. doi: 10.1128/iai.31.3.1223-1231.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Ström J. Further experience of reactions, especially of a cerebral nature, in conjunction with triple vaccination: a study based on vaccinations in Sweden 1959-65. Br Med J. 1967 Nov 11;4(5575):320–323. doi: 10.1136/bmj.4.5575.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Ström J. Is Universal Vaccination Against Pertussis Always Justified? Br Med J. 1960 Oct 22;2(5207):1184–1186. [PMC free article] [PubMed] [Google Scholar]
  50. Taylor E. M., Emergy J. L. Immunization and cot deaths. Lancet. 1982 Sep 25;2(8300):721–721. doi: 10.1016/s0140-6736(82)90745-0. [DOI] [PubMed] [Google Scholar]
  51. Toyota T., Kai Y., Kakizaki M., Sakai A., Goto Y., Yajima M., Ui M. Effects of islet-activating protein (IAP) on blood glucose and plasma insulin in healthy volunteers (phase 1 studies). Tohoku J Exp Med. 1980 Feb;130(2):105–116. doi: 10.1620/tjem.130.105. [DOI] [PubMed] [Google Scholar]
  52. Trollfors B., Rabo E. Whooping cough in adults. Br Med J (Clin Res Ed) 1981 Sep 12;283(6293):696–697. doi: 10.1136/bmj.283.6293.696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Tuomanen E., Weiss A. Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells. J Infect Dis. 1985 Jul;152(1):118–125. doi: 10.1093/infdis/152.1.118. [DOI] [PubMed] [Google Scholar]
  54. Valenti W. M., Pincus P. H., Messner M. K. Nosocomial pertussis: possible spread by a hospital visitor. Am J Dis Child. 1980 May;134(5):520–521. doi: 10.1001/archpedi.1980.02130170070023. [DOI] [PubMed] [Google Scholar]
  55. Weiss A. A., Hewlett E. L. Virulence factors of Bordetella pertussis. Annu Rev Microbiol. 1986;40:661–686. doi: 10.1146/annurev.mi.40.100186.003305. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES